These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
489 related items for PubMed ID: 18266357
1. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations. Zeng J, Li W, Zhao Y, Liu G, Tang Y, Jiang H. J Phys Chem B; 2008 Mar 06; 112(9):2719-26. PubMed ID: 18266357 [Abstract] [Full Text] [Related]
2. Computational insights into the mechanism of ligand unbinding and selectivity of estrogen receptors. Shen J, Li W, Liu G, Tang Y, Jiang H. J Phys Chem B; 2009 Jul 30; 113(30):10436-44. PubMed ID: 19583238 [Abstract] [Full Text] [Related]
3. Use of binding energy in comparative molecular field analysis of isoform selective estrogen receptor ligands. Wolohan P, Reichert DE. J Mol Graph Model; 2004 Sep 30; 23(1):23-38. PubMed ID: 15331051 [Abstract] [Full Text] [Related]
4. Structure-based design of estrogen receptor-beta selective ligands. Manas ES, Unwalla RJ, Xu ZB, Malamas MS, Miller CP, Harris HA, Hsiao C, Akopian T, Hum WT, Malakian K, Wolfrom S, Bapat A, Bhat RA, Stahl ML, Somers WS, Alvarez JC. J Am Chem Soc; 2004 Nov 24; 126(46):15106-19. PubMed ID: 15548008 [Abstract] [Full Text] [Related]
5. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. van Lipzig MM, ter Laak AM, Jongejan A, Vermeulen NP, Wamelink M, Geerke D, Meerman JH. J Med Chem; 2004 Feb 12; 47(4):1018-30. PubMed ID: 14761204 [Abstract] [Full Text] [Related]
6. Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity. Burendahl S, Danciulescu C, Nilsson L. Proteins; 2009 Dec 12; 77(4):842-56. PubMed ID: 19626711 [Abstract] [Full Text] [Related]
7. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics. Celik L, Lund JD, Schiøtt B. Biochemistry; 2007 Feb 20; 46(7):1743-58. PubMed ID: 17249692 [Abstract] [Full Text] [Related]
8. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Escande A, Pillon A, Servant N, Cravedi JP, Larrea F, Muhn P, Nicolas JC, Cavaillès V, Balaguer P. Biochem Pharmacol; 2006 May 14; 71(10):1459-69. PubMed ID: 16554039 [Abstract] [Full Text] [Related]
9. Ligand selectivity of estrogen receptors by a molecular dynamics study. Hu G, Wang J. Eur J Med Chem; 2014 Mar 03; 74():726-35. PubMed ID: 23694906 [Abstract] [Full Text] [Related]
11. New computational strategy to analyze the interactions of ERalpha and ERbeta with different ERE sequences. Marabotti A, Colonna G, Facchiano A. J Comput Chem; 2007 Apr 30; 28(6):1031-41. PubMed ID: 17269124 [Abstract] [Full Text] [Related]
12. Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia. Norman BH, Dodge JA, Richardson TI, Borromeo PS, Lugar CW, Jones SA, Chen K, Wang Y, Durst GL, Barr RJ, Montrose-Rafizadeh C, Osborne HE, Amos RM, Guo S, Boodhoo A, Krishnan V. J Med Chem; 2006 Oct 19; 49(21):6155-7. PubMed ID: 17034120 [Abstract] [Full Text] [Related]
13. Mouse estrogen receptor beta isoforms exhibit differences in ligand selectivity and coactivator recruitment. Zhao C, Toresson G, Xu L, Koehler KF, Gustafsson JA, Dahlman-Wright K. Biochemistry; 2005 Jun 07; 44(22):7936-44. PubMed ID: 15924412 [Abstract] [Full Text] [Related]
14. Lessons learnt from structural studies of the oestrogen receptor. Pike AC. Best Pract Res Clin Endocrinol Metab; 2006 Mar 07; 20(1):1-14. PubMed ID: 16522516 [Abstract] [Full Text] [Related]
15. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes. Tuccinardi T, Bertini S, Martinelli A, Minutolo F, Ortore G, Placanica G, Prota G, Rapposelli S, Carlson KE, Katzenellenbogen JA, Macchia M. J Med Chem; 2006 Aug 10; 49(16):5001-12. PubMed ID: 16884312 [Abstract] [Full Text] [Related]
16. Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators. Güngör T, Chen Y, Golla R, Ma Z, Corte JR, Northrop JP, Bin B, Dickson JK, Stouch T, Zhou R, Johnson SE, Seethala R, Feyen JH. J Med Chem; 2006 Apr 20; 49(8):2440-55. PubMed ID: 16610787 [Abstract] [Full Text] [Related]
17. Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative diseases. Zhao L, Brinton RD. J Med Chem; 2005 May 19; 48(10):3463-6. PubMed ID: 15887952 [Abstract] [Full Text] [Related]
18. Binding free energies and free energy components from molecular dynamics and Poisson-Boltzmann calculations. Application to amino acid recognition by aspartyl-tRNA synthetase. Archontis G, Simonson T, Karplus M. J Mol Biol; 2001 Feb 16; 306(2):307-27. PubMed ID: 11237602 [Abstract] [Full Text] [Related]
19. Role of aspartate 351 in transactivation and active conformation of estrogen receptor alpha. Kim JH, Lee MH, Kim BJ, Kim JH, Han SJ, Kim HY, Stallcup MR. J Mol Endocrinol; 2005 Dec 16; 35(3):449-64. PubMed ID: 16326832 [Abstract] [Full Text] [Related]
20. Insights into activation and RNA binding of trp RNA-binding attenuation protein (TRAP) through all-atom simulations. Murtola T, Vattulainen I, Falck E. Proteins; 2008 Jun 16; 71(4):1995-2011. PubMed ID: 18186477 [Abstract] [Full Text] [Related] Page: [Next] [New Search]